Study Summary
This trial will study the effects of a T5 ESP block on the body. The primary objectives are to see how far the anesthesia spreads and how long it lasts.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
4 Primary · 3 Secondary · Reporting Duration: These samples will be repeated at 20, 40, 60, 90, 120, and 240 minutes after completion of the injection of active drug.
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Ropivacaine without Epinephrine
1 of 2
Ropivacaine with Epinephrine
1 of 2
Active Control
24 Total Participants · 2 Treatment Groups
Primary Treatment: Ropivacaine without Epinephrine · No Placebo Group · Phase 4
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 60 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How extensive is the participation in this clinical experiment?
"Yes, clinicaltrials.gov reveals that this trial is actively soliciting volunteers and has been so since it was initially posted on July 2nd 2019. The study requires 24 participants to be enrolled at two designated centres before the last edit of January 9th 2022." - Anonymous Online Contributor
What medical issues can be addressed with Ropivacaine unaccompanied by Epinephrine?
"Ropivacaine, unaccompanied by Epinephrine, can be administered to treat hypotension, pupil dilation and cardiac unresponsiveness." - Anonymous Online Contributor
What data has been gathered from other investigations regarding Ropivacaine without Epinephrine?
"Presently, there are 90 active investigations looking into the utility of Ropivacaine without Epinephrine and 19 studies have reached Phase 3. Though most centres conducting research on this topic are found in Karachi, Sindh; 128 distinct sites across the world are running trials for Ropivacaine without Epinephrine." - Anonymous Online Contributor
Are there any openings for applicants in this clinical trial?
"Affirmative. According to the information on clinicaltrials.gov, this research initiative is actively searching for participants. The trial was initiated on July 2nd 2019 and has been recently updated as of January 9th 2022; it requires 24 volunteers at two different sites." - Anonymous Online Contributor
Does this research encompass adults aged 30 or older?
"The parameters for inclusion in this trial limit participants to those between 18 and 60 years of age. There are 16 studies available for minors under 18, and 67 trials targeting individuals over 65." - Anonymous Online Contributor
Has the Food and Drug Administration approved Ropivacaine without Epinephrine?
"According to our team at Power, Ropivacaine without Epinephrine has been approved for use and thus receives a score of 3 on the safety scale." - Anonymous Online Contributor
What criteria must a participant fulfill in order to be accepted into this trial?
"For admittance to this trial, applicants must have evidence of the distribution of ropivacaine in erector spinae plane block and be within the age range 18-60 years. A maximum of 24 participants will be accepted into the study." - Anonymous Online Contributor